Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Avidity Biosciences, Inc. (RNA) Return on Assets (2020 - 2025)

Avidity Biosciences' Return on Assets history spans 6 years, with the latest figure at 0.33% for Q4 2025.

  • For Q4 2025, Return on Assets fell 13.0% year-over-year to 0.33%; the TTM value through Dec 2025 reached 0.33%, down 13.0%, while the annual FY2025 figure was 0.39%, 9.0% down from the prior year.
  • Return on Assets reached 0.33% in Q4 2025 per RNA's latest filing, down from 0.31% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.19% in Q3 2024 to a low of 0.38% in Q3 2022.
  • Average Return on Assets over 5 years is 0.29%, with a median of 0.3% recorded in 2022.
  • Peak YoY movement for Return on Assets: dropped -16bps in 2021, then increased 15bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.28% in 2021, then fell by -18bps to 0.33% in 2022, then decreased by -8bps to 0.35% in 2023, then surged by 43bps to 0.2% in 2024, then crashed by -66bps to 0.33% in 2025.
  • Per Business Quant, the three most recent readings for RNA's Return on Assets are 0.33% (Q4 2025), 0.31% (Q3 2025), and 0.32% (Q2 2025).